Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03729830 · ClinicalTrials.gov registry record
Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 415
- Enrollment target
NCT03729830 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 415 participants.
The verdict
NCT03729830 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 415 participants
- Enrollment target
Study Summary
To obtain data for the Rhythmia™ Mapping System in conjunction with Boston Scientific Open-Irrigated (OI) Catheters for ablation of Paroxysmal Atrial Fibrillation (PAF) according to current international and local guidelines. Primary objective: To assess acute and long-term outcomes for the Rhythmia Mapping System in conjunction with Boston Scientific Open-Irrigated Ablation Catheters to treat de novo Paroxysmal Atrial Fibrillation. De Novo PAF is defined as subjects undergoing first ablation procedure for PAF with no prior left atrial ablation (RF, Cryo, Surgical).
Interventions
- DEVICE Boston Scientific Open Irrigated Ablation Catheters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2024-05-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03729830
The ClinicalTrials.gov registry entry for NCT03729830 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 415 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Boston Scientific Open Irrigated Ablation Catheters is the first listed.
NCT03729830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03729830 about?
NCT03729830 is a clinical study titled "Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation". To obtain data for the Rhythmia™ Mapping System in conjunction with Boston Scientific Open-Irrigated (OI) Catheters for ablation of Paroxysmal Atrial Fibrillation (PAF) according to current international and local guidelines. Primary objective: To assess acute and long-term outcomes for the Rhythmi...
What is the current status of trial NCT03729830?
This trial is currently completed. The enrollment target is 415 participants. The study started on 2019-03-04. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT03729830?
The interventions under investigation include: Boston Scientific Open Irrigated Ablation Catheters (DEVICE).
Who is sponsoring clinical trial NCT03729830?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.